Neonatal Enhanced Recovery After Surgery (ERAS) Outcomes Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age24-44
SponsorThe Hospital for Sick Children

About this trial

The goal of this observational study is to improve the way newborn babies are cared for before, during, and after major surgery. Surgery can be very stressful on a baby's body. This study looks at whether a structured care plan called Neonatal Enhanced Recovery After Surgery (nERAS) can help reduce complications and improve recovery.

This study has three main goals:

1. To evaluate whether the nERAS guidelines improve short-term health outcomes for newborns who need major surgery, 2. To understand how well the guidelines are adopted and followed by healthcare teams, 3. To study longer-term development outcomes (up to 18 months after surgery) for a group of babies treated under this care pathway.

Researchers will compare babies who received standard surgical care before nERAS was introduced with babies who received care after nERAS was implemented with a multifaceted implementation strategy. This will help determine whether the guidelines improve recovery and overall outcomes.

The study involves reviewing medical records of newborns who had surgery. In addition, healthcare providers and parents or caregivers may be asked to complete surveys or participate in interviews or focus groups to share their experiences with this care approach.

Eligibility criteria

Qualifiers

Consent provided by parent/legal guardian

Infant aged ≥24 weeks gestational age at birth and <cGA 44 weeks at time of index surgery

Requires major non-cardiac surgery requiring general anesthetic (e.g., thoracotomy, laparotomy, ventriculoperitoneal shunt, choanal atresia repair, etc.)

Admitted preoperatively to a study NICU (HSC, ACH, or GOSH)

Disqualifiers

Infants undergoing cardiac surgery as sole index surgical intervention, sole minor index surgery (e.g., central line placement, eye exam under anesthesia)

Born at less than 24 weeks estimated gestational age or greater than 44 weeks corrected gestation age on day of index surgery

Intraoperative mortality

Genetic anomaly associated with lethality (e.g., trisomy 13 or 18)

Trial design

Treatments tested in this trial

  • Pre-nERAS Guideline Implementation Intervention
  • Multifaceted Implementation of nERAS Guideline Intervention

Treatment groups

400 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The Hospital for Sick Children

Lead sponsor

Alberta Children's Hospital

Collaborator

Great Ormond Street Hospital for Children NHS Foundation Trust

Collaborator